The emergence of a new paradigm with signal 1 and signal 2 T-cell engagers in hematology
{{output}}
First-generation T-cell engagers have demonstrated significant efficacy in treating hematological malignancies by providing a potent T-cell receptor Signal 1. However, their efficacy is limited by the absence of a TCR co-stimulatory Signal 2, which results in ... ...
